Log in
Enquire now
Arctoris

Arctoris

A biotechnology company with a drug discovery platform intended to be used for research purposes. It was founded in 2016 and has offices in Oxford, England and Singapore.

OverviewStructured DataIssuesContributors

Contents

arctoris.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Machine learning
Machine learning
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Technology
Technology
‌
Cloud robotics
Biology
Biology
Drug discovery
Drug discovery
...
Location
Boston
Boston
0
United Kingdom
United Kingdom
Oxford
Oxford
0
Singapore
Singapore
0
B2X
B2B
B2B
0
B2C
B2C
CEO
Martin-Immanuel Bittner
Martin-Immanuel Bittner
0
Founder
Martin-Immanuel Bittner
Martin-Immanuel Bittner
0
Thomas Fleming
Thomas Fleming
0
AngelList URL
angel.co/arctoris
Number of Employees (Ranges)
11 – 500
Email Address
welcome@arctoris.com
Full Address
68 Circular Road #02-01 Singapore 049422 SINGAPORE0
120E Olympic Avenue Milton Park Abingdon OX14 4SA UNITED KINGDOM0
6 Liberty Square # 6152 Boston, MA 02109 USA0
Investors
Creative Destruction Lab
Creative Destruction Lab
‌
Tanarra Capital
Founded Date
2016
Competitors
Oxford Drug Design Limited
Oxford Drug Design Limited
Synthace
Synthace
Patents Assigned (Count)
1
COO
Thomas Fleming
Thomas Fleming
0
Wellfound ID
arctoris
Country
United Kingdom
United Kingdom
0
Singapore
Singapore
0
United States
United States
0

Other attributes

Company Operating Status
Active
About

Arctoris is an Oxford-based biotechnology and artificial intelligence company that has developed a platform to be used for the research and development of drugs for diseases such as cancer. The platform is used in industries such as biotechnology, pharmaceuticals, academia, and artificial intelligence drug discovery.

Product

The platform allows for researchers to design their experiment with an online configurator and also gives them access to a team of experts prior the initiation of the experiment. Arctoris then has its own robotics perform the experiments remotely as per the researchers' specifications. Researchers can see the results of the experiment in real-time using the platform.

The platform works with in silico drug discovery and provides a range of assays and techniques. The company offers services for both cell-based assays and target-based assays.During the COVID-19 pandemic, Arctoris offered services such as biochemical profiling, molecular assays, and its cellular assays.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Arctoris announces partnership with Molecule to tackle the innovation crisis in drug discovery and development

https://www.pharmiweb.com/press-release/2020-02-17/arctoris-announces-partnership-with-molecule-to-tackle-the-innovation-crisis-in-drug-discovery-and-development

Web

February 10, 2020

Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform Powered by Robotics

https://www.biospace.com/article/arctoris-ltd-secures-seed-funding-of-3-2-million-to-advance-novel-drug-discovery-platform-powered-by-robotics/

Web

September 30, 2019

ARCTURIS

https://www.arcturis.com/

Web

References

Find more companies like Arctoris

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us